General Information of Drug Transporter (DT)
DT ID DTD0037 Transporter Info
Gene Name ABCA10
Transporter Name ATP-binding cassette sub-family A member 10
Gene ID
10349
UniProt ID
Q8WWZ4
Post-Translational Modification of This DT
Overview of ABCA10 Modification Sites with Functional and Structural Information
Sequence
MNKMALASFM KGRTVIGTPD EETMDIELPK KYHEMVGVIF SDTFSYRLKF NWGYRIPVIK 
EHSEYTEHCW AMHGEIFCYL AKYWLKGFVA FQAAINAAII EVTTNHSVME ELTSVIGINM 
KIPPFISKGE IMNEWFHFTC LVSFSSFIYF ASLNVARERG KFKKLMTVMG LRESAFWLSW 
GLTYICFIFI MSIFMALVIT SIPIVFHTGF MVIFTLYSLY GLSLIALAFL MSVLIRKPML 
AGLAGFLFTV FWGCLGFTVL YRQLPLSLGW VLSLLSPFAF TAGMAQITHL DNYLSGVIFP 
DPSGDSYKMI ATFFILAFDT LFYLIFTLYF ERVLPDKDGH GDSPLFFLKS SFWSKHQNTH 
HEIFENEINP EHSSDDSFEP VSPEFHGKEA IRIRNVIKEY NGKTGKVEAL QGIFFDIYEG 
QITAILGHNG AGKSTLLNIL SGLSVSTEGS ATIYNTQLSE ITDMEEIRKN IGFCPQFNFQ 
FDFLTVRENL RVFAKIKGIQ PKEVEQEVKR IIMELDMQSI QDIIAKKLSG GQKRKLTLGI 
AILGDPQVLL LDEPTAGLDP FSRHRVWSLL KEHKVDRLIL FSTQFMDEAD ILADRKVFLS 
NGKLKCAGSS LFLKRKWGIG YHLSLHRNEM CDTEKITSLI KQHIPDAKLT TESEEKLVYS 
LPLEKTNKFP DLYSDLDKCS DQGIRNYAVS VTSLNEVFLN LEGKSAIDEP DFDIGKQEKI 
HVTRNTGDES EMEQVLCSLP ETRKAVSSAA LWRRQIYAVA TLRFLKLRRE RRALLCLLLV 
LGIAFIPIIL EKIMYKVTRE THCWEFSPSM YFLSLEQIPK TPLTSLLIVN NTGSNIEDLV 
HSLKCQDIVL EIDDFRNRNG SDDPSYNGAI IVSGDQKDYR FSVACNTKKL NCFPVLMGIV 
SNALMGIFNF TELIQMESTS FSRDDIVLDL GFIDGSIFLL LITNCVSPFI GMSSISDYKK 
NVQSQLWISG LWPSAYWCGQ ALVDIPLYFL ILFSIHLIYY FIFLGFQLSW ELMFVLVVCI 
IGCAVSLIFL TYVLSFIFRK WRKNNGFWSF GFFIILICVS TIMVSTQYEK LNLILCMIFI 
PSFTLLGYVM LLIQLDFMRN LDSLDNRINE VNKTILLTTL IPYLQSVIFL FVIRCLEMKY 
GNEIMNKDPV FRISPRSRET HPNPEEPEEE DEDVQAERVQ AANALTAPNL EEEPVITASC 
LHKEYYETKK SCFSTRKKKI AIRNVSFCVK KGEVLGLLGH NGAGKSTSIK MITGCTKPTA 
GVVVLQGSRA SVRQQHDNSL KFLGYCPQEN SLWPKLTMKE HLELYAAVKG LGKEDAALSI 
SRLVEALKLQ EQLKAPVKTL SEGIKRKLCF VLSILGNPSV VLLDEPFTGM DPEGQQQMWQ 
ILQATVKNKE RGTLLTTHYM SEAEAVCDRM AMMVSGTLRC IGSIQHLKNK FGRDYLLEIK 
MKEPTQVEAL HTEILKLFPQ AAWQERYSSL MAYKLPVEDV HPLSRAFFKL EAMKQTFNLE 
EYSLSQATLE QVFLELCKEQ ELGNVDDKID TTVEWKLLPQ EDP
PTM type
X-Acetylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA10 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

527

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at ABCA10 Lysine 527 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA10 [2]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

533

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at ABCA10 Lysine 533 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA10 [3]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

1139

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at ABCA10 Lysine 1139 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        12 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA10 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

519

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 519 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA10 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

529

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 529 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA10 [6] , [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

568

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 568 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA10 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

638

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 638 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCA10 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

730

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 730 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCA10 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

738

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 738 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1154

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1154 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1271

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1271 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1279

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1279 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1291

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1291 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence ABCA10 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1319

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1319 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1415

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Serine 1415 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA10 [11]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

742

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Threonine 742 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA10 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

761

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Threonine 761 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA10 [13]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

887

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Threonine 887 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA10 [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1417

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Threonine 1417 has the potential to affect its expression or activity.

  Tyrosine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCA10 [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

54

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 54 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCA10 [7] , [16]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

307

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 307 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCA10 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

757

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 757 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

795

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 795 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCA10 [17]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

879

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 879 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1140

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 1140 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCA10 [10]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

1285

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCA10 Tyrosine 1285 has the potential to affect its expression or activity.
References
1 An outbreak of dysentery caused by Sh. flexneri var. X. Zh Mikrobiol Epidemiol Immunobiol. 1975 Nov;(11):123-4.
2 The combined effect of supraoptimal temperature and chemotherapeutic preparations on the metabolism of adenylic nucleotides by Staphylococcus aureus. Zh Mikrobiol Epidemiol Immunobiol. 1975 Nov;(11):58-61.
3 Application of hyphenated chromatography-mass spectrometry techniques to plant allelopathy research. J Chem Ecol. 2001 Dec;27(12):2363-96.
4 The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies. J Proteomics. 2016 Jan 10;131:190-198.
5 HOPE-fixation of lung tissue allows retrospective proteome and phosphoproteome studies. J Proteome Res. 2014 Nov 7;13(11):5230-9.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
8 Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission. Haematologica. 2012 Jun;97(6):915-8.
9 Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors. Haematologica. 2012 May;97(5):723-30.
10 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ABCAA_HUMAN)
11 The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood. 2012 Feb 2;119(5):1182-9.
12 Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int J Mol Sci. 2015 Feb 16;16(2):4209-25.
13 Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem. 2000 Jul 28;275(30):22756-63.
14 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
15 Duodenal ulcer in the new-born (author's transl). Sem Hop. 1979 Mar;55(1112):613-7.
16 Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat Methods. 2005 Aug;2(8):591-8.
17 Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem. 2000 Jul 21;275(29):22245-54.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.